Glaxosmithkline Pharmaceuticals Ltd
GLAXO price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- GLAXO
- MB Code
- MBEQU3830
- ISIN
- INE159A01016
- BSE code
- 500660
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 995.3 Cr
- Net profit
- 277.86 Cr
- EPS
- 16.4
- YoY revenue
- +2.15%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for GLAXO
Dividend of ₹57.00 per share
Ex-date corporate action
GlaxoSmithKline Pharmaceuticals reported Q4 FY2026 earnings, with full-year EBITDA up 11% and PAT crossing 1,000 for the first time, high…
On February 9, 2026, GlaxoSmithKline Pharmaceuticals Ltd reported a 28.6% increase in Q3 net profit to ₹295.6 crore, driven by a 9.7% ris…
The IPO details for GlaxoSmithKline Pharmaceuticals Ltd. include the Issue Open and Close Dates, along with information on subscription a…
Price returns
Historical performance
Technicals
Indicator consensus